The 564 gives a bigger N values, better confidence in the stats with the 564 group being true for the entire population, helps with safety data.
Bottom line though, I believe it will drop the number the FDA requires in the pivotal trial.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-